In addition, the administration of a fusion protein of TNFα targeting tumor vessels can rescue their normal permeability and promote tumor infiltration by cytotoxic T lymphocytes, enhancing the effectiveness of immune checkpoint inhibitors. The gene discussed is TNF; the disease is neoplasm.